1998
DOI: 10.1016/s0960-894x(98)00037-7
|View full text |Cite
|
Sign up to set email alerts
|

4-Alkylpiperidines related to SR-48968: Potent antagonists of the neurokinin-2 (NK2) receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

1998
1998
2017
2017

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…Neurokinin antagonists are implicated in a variety of disease states, including migraine, emesis, pain, arthritis, asthma, depression, and anxiety. Many neurokinin-1 receptor antagonists have been reported in the literature based on the arylpiperidine scaffold. ,, Less effort has been applied to the discovery of non-peptide antagonists of the neurokinin-2 and -3 receptors . Possible applications of drugs specific for these receptors include the treatment of asthma, as well as psychosis and anxiety. , It should be noted that the endogenous ligands of the neurokinin-1, -2, and -3 receptors (substance P, neurokinin A, and neurokinin B, respectively) have the highest affinity for their native receptor subtypes, but all three peptides have a relatively high affinity for, and are able to act as full agonists for all three receptor subtypes 3 The cis -(2 S ,3 S )-piperidine framework is a basic framework for high-affinity neurokinin-1 receptor (NK 1 ) antagonists …”
Section: B Arylpiperidinesmentioning
confidence: 99%
See 1 more Smart Citation
“…Neurokinin antagonists are implicated in a variety of disease states, including migraine, emesis, pain, arthritis, asthma, depression, and anxiety. Many neurokinin-1 receptor antagonists have been reported in the literature based on the arylpiperidine scaffold. ,, Less effort has been applied to the discovery of non-peptide antagonists of the neurokinin-2 and -3 receptors . Possible applications of drugs specific for these receptors include the treatment of asthma, as well as psychosis and anxiety. , It should be noted that the endogenous ligands of the neurokinin-1, -2, and -3 receptors (substance P, neurokinin A, and neurokinin B, respectively) have the highest affinity for their native receptor subtypes, but all three peptides have a relatively high affinity for, and are able to act as full agonists for all three receptor subtypes 3 The cis -(2 S ,3 S )-piperidine framework is a basic framework for high-affinity neurokinin-1 receptor (NK 1 ) antagonists …”
Section: B Arylpiperidinesmentioning
confidence: 99%
“…186 Possible applications of drugs specific for these receptors include the treatment of asthma, as well as psychosis and anxiety. 186,190 It should be noted that the endogenous ligands of the neurokinin-1, -2, and -3 receptors (substance P, neurokinin A, and neurokinin B, respectively) have the highest affinity for their native receptor subtypes, but all three peptides have a relatively high affinity for, and are able to act as full agonists for all three receptor subtypes. 186 The arylpiperidine moiety is also found in antagonists for other neuroreceptors.…”
Section: B Arylpiperidinesmentioning
confidence: 99%
“…There are several examples that playing an important role in medicinal and pharmaceutical chemistry [2], including Esomeprazole [7,8], which acts as proton-pump inhibitor; the selective NK 2 antagonist ZD7944 [9]; and the anti-cancer agent Sulindac ® (Figure 1) [10].…”
Section: Introductionmentioning
confidence: 99%
“…There are several examples that playing an important role in medicinal and pharmaceutical chemistry [2], including Esomeprazole [7,8], which acts as proton-pump inhibitor; the selective NK2 antagonist ZD7944 [9]; and the anti-cancer agent Sulindac ® (Figure 1) [10]. Modafinil (also known as Provigil ® [11], Figure 2), another important sulfoxide, is administered as a drug against narcolepsy [12] with significant advantages compared to dexamphetamine [13] and several other stimulants [14] because of a lower abuse potential [15,16].…”
Section: Introductionmentioning
confidence: 99%
“…To date, in addition to a number of peptidic antagonists, , there are currently two main classes of nonpeptidic NK 2 receptor antagonists (Figure ); the benzamide piperidine antagonists, e.g., 1 , and those derived from indolium piperidines, e.g., 2 (Figure ). Although much elegant work has been done to refine the structure−activity relationships within these classes, essentially all of the known antagonists have resulted from compound library screening methods.…”
mentioning
confidence: 99%